Nomegestrol and chlormadinone containing medicines: Measures to minimise the risk of meningioma
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Active substance |
|
Procedure number |
EMEA/H/A-31/1510
|
Regulatory outcome |
Variation
|
DHPC type |
|
Referral name |
Nomegestrol and chlormadinone
|
Human ATC code |
G03
|
Dissemination date |
08/11/2022
|